Crinetics Hosting Key Opinion Leader Webinar to Discuss the Current Treatment Landscape and Unmet Need in Acromegaly
July 31, 2023 08:01 ET
|
Crinetics Pharmaceuticals, Inc.
SAN DIEGO, July 31, 2023 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will host a Key Opinion Leader (KOL) webinar on August 8, 2023 at 12:00 pm Eastern...
Tonix Pharmaceuticals Announces Enrollment Initiated in the MGH Phase 2 ‘STROBE’ Study of TNX-1900 (Intranasal Potentiated Oxytocin) for the Treatment of Binge-Eating Disorder
July 31, 2023 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
Preliminary Data Show that Oxytocin Decreases Impulsivity and Reduces Food Intake TNX-1900 (Intranasal Potentiated Oxytocin) May Serve as a Novel Neuroendocrine Treatment for Binge-Eating Disorder ...
Tonix Pharmaceuticals Announces Initiation of Enrollment in the MGH Phase 2 ‘POWER’ Study of TNX-1900 (Intranasal Potentiated Oxytocin) for the Treatment of Pediatric Obesity
July 10, 2023 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
Preliminary Data Suggest that Oxytocin May Simultaneously Reduce Energy Intake and Increase Energy Expenditure TNX-1900 (Intranasal Potentiated Oxytocin) May Serve as a Novel Neuroendocrine...
Extracellular Vesicles 2023: Drug Delivery, Biologics & Therapeutics Conference (Orlando, Florida, United States - July 26-27, 2023)
July 03, 2023 04:38 ET
|
Research and Markets
Dublin, July 03, 2023 (GLOBE NEWSWIRE) -- The "Extracellular Vesicles 2023: Drug Delivery, Biologics & Therapeutics" conference has been added to ResearchAndMarkets.com's offering.Welcome to...
Extracellular Vesicles Conference 2023: Technologies, Biomarker Cargo & Diagnostics (Orlando, Florida, United States - July 26-27, 2023)
June 28, 2023 05:08 ET
|
Research and Markets
Dublin, June 28, 2023 (GLOBE NEWSWIRE) -- The "Extracellular Vesicles 2023: Technologies, Biomarker Cargo & Diagnostics" conference has been added to ResearchAndMarkets.com's offering.Welcome...
James Heffernan Receives HFMA Individual Achievement Award
June 27, 2023 10:30 ET
|
Healthcare Financial Management Association (HFMA)
NASHVILLE, Tenn., June 27, 2023 (GLOBE NEWSWIRE) -- The Healthcare Financial Management Association (HFMA) today presented James L. Heffernan, FHFMA, MBA, with the 2023 Frederick C. Morgan...
Bitterroot Bio Launches Out of Stealth with $145 Million Series A Financing to Develop Transformative Medicines in Cardio-immunology
June 07, 2023 08:00 ET
|
Bitterroot Bio
Founders, Executive Team, and Advisors are recognized scientific and clinical pioneers in the fields of immunology and cardiology Series A financing co-led by ARCH Venture Partners and Deerfield...
BioSenic fait le point sur ses activités du premier trimestre 2023
May 22, 2023 01:00 ET
|
BioSenic
INFORMATION RÉGLEMENTÉE Résultats principaux ALLOB Phase IIb prévus en Juillet/Août 2023 Discussions en cours en vue de partenariats clés pour les actifs cliniques avancés Mont-Saint-Guibert,...
Jasper Therapeutics Announces Appointment of Stephen J. Galli, M.D. to Scientific Advisory Board
May 10, 2023 08:00 ET
|
Jasper Therapeutics
REDWOOD CITY, Calif., May 10, 2023 (GLOBE NEWSWIRE) -- Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper), a biotechnology company focused on development of briquilimab, a novel antibody therapy...
Tonix Pharmaceuticals Reports First Quarter 2023 Financial Results and Operational Highlights
May 08, 2023 07:00 ET
|
Tonix Pharmaceuticals Holding Corp.
Prioritizing Late-Stage Clinical CNS Programs in Fibromyalgia, Depression, Migraine, and Cocaine Intoxication Topline Results Expected in Fourth Quarter 2023 for Potentially Confirmatory Phase 3...